Use of interferon beta for acute respiratory distress syndrome: proceed with caution

Lancet Respir Med. 2014 Apr;2(4):e2. doi: 10.1016/S2213-2600(14)70048-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 5'-Nucleotidase / metabolism*
  • Adjuvants, Immunologic / therapeutic use*
  • Female
  • Humans
  • Interferon-beta / therapeutic use*
  • Lung / metabolism*
  • Male
  • Respiratory Distress Syndrome / drug therapy*
  • Respiratory Distress Syndrome / metabolism*

Substances

  • Adjuvants, Immunologic
  • Interferon-beta
  • 5'-Nucleotidase